Company intelligence / Profile preview

Pillar Biosciences

Natick, Massachusetts, United Statespillarbiosci.com ↗

Ownership: Private
Employees: ~72
Development stage: Commercial

Overview

Pillar Biosciences has developed and commercialized next-generation sequencing diagnostic solutions, including the FDA-approved oncoReveal® CDx Pan-Cancer Solid Tumor IVD Kit. Their platforms enable rapid, accurate genomic profiling to support precision oncology decisions at the point of care. The company’s technologies have received regulatory approvals and CMS coverage for reimbursement.

Therapeutic areas: Oncology
Modalities: Next-generation sequencing (NGS) diagnosticsin vitro diagnostics (IVD)cell-free DNA analysistargeted sequencing panels
Industry: Molecular Diagnostics

Partnerships

Hamilton Company – co-marketing agreement for NGS application development

Beyond the preview

Go deeper on Pillar Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pillar Biosciences.

Explore the full profile